Schedule 13D ownership disclosure
NIVALIS THERAPEUTICS INC
Security class unavailable · CUSIP: 65481J109
Event date: 2017-04-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 23.8400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-17-000691
- Form type
- SC 13D
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- Apr 25, 2017
- Reporting period
- Apr 17, 2017
- Description
- Schedule 13D beneficial ownership